Population implications of changes in lipid management in patients with coronary heart disease.
Pharmacologic treatment and goal attainment rates from published literature indicate that lipid management has generally improved for patients with coronary heart disease. The population implications of these changes in lipid management are examined, suggesting that the challenge of lipid management may be shifting from a problem of no treatment to one of undertreatment.
Foley
Kathleen A
KA
Outcomes Research & Management, U.S. Medical & Scientific Affairs, Merck & Co., Inc., West Point, Pennsylvania, USA.
Massing
Mark W
MW
Simpson
Ross J
RJ
Alexander
Charles M
CM
Markson
Leona E
LE
D000328:Adult; D000465:Algorithms; D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood* / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D010043:Outcome and Process Assessment, Health Care; D014481:United States / Q000453:epidemiology
D008078:Cholesterol, LDL; D008055:Lipids